Harvest Management’s Cytokinetics CYTK Stock Holding History

Harvest Management’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.06M	Buy	12,400 +1,400	+13%	+$101K	0.42%	32
2026 Q1	$725K	Sell	11,000 -2,600	-19%	-$165K	0.35%	32
2025 Q4	$864K	Buy	13,600 +1,000	+8%	+$62.2K	0.28%	38
2025 Q3	$692K	Buy	12,600 +1,856	+17%	+$76.5K	0.3%	40
2025 Q2	$355K	Sell	10,744 -1,000	-9%	-$34.8K	0.15%	48
2025 Q1	$472K	Buy	11,744 +544	+5%	+$25K	0.21%	38
2024 Q4	$527K	Buy	11,200 +300	+3%	+$15.6K	0.25%	39
2024 Q3	$576K	Sell	10,900 -3,300	-23%	-$184K	0.29%	34
2024 Q2	$769K	Buy	14,200 +9,200	+184%	+$555K	0.59%	27
2024 Q1	$351K	Sell	5,000 -10,000	-67%	-$773K	0.24%	40
2023 Q4	$1.25M	Buy	+15,000	New	+$543K	1.16%	20

Other funds holding CYTK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harvest Management's CYTK Position: Q2 2026 in Review

Harvest Management increased its Cytokinetics (CYTK) stake by 13% in Q2 2026, buying an estimated $101K and bringing the position to 12,400 shares worth $1.06M. The position accounts for 0.42% of the portfolio, ranked #32.

Harvest Management first reported a position in CYTK in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.25M in Q4 2023. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

Harvest Management held 12,400 shares of Cytokinetics worth $1.06M as of Q2 2026.
Harvest Management bought 1,400 Cytokinetics shares in Q2 2026, an estimated $101K.
Cytokinetics made up 0.42% of Harvest Management's portfolio in Q2 2026, its #32 holding.
Harvest Management first reported a position in Cytokinetics in Q4 2023 and has held it in 11 quarters since.
Harvest Management's Cytokinetics position peaked at $1.25M in Q4 2023.
482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Harvest Management's 13F filing for Q2 2026, filed 14 Aug 2026.